Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism

References

• Ago Y, Koyama Y, Baba A, Matsuda T. Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex. Neuropharmacology 2003; 45: 1050–1056
   PubMed Web of Science ®Google Scholar
• Drzezga A, Arnold S, Minoshima S, et al. 18F-FDG PET studies in patients with extratemporal and temporal epilepsy: Evaluation of an observer-independent analysis. J Nucl Med 1999; 40: 737–746
   PubMed Web of Science ®Google Scholar
• Fellgiebel A, Scheurich A, Siessmeier T, Schmidt LG, Bartenstein P. Persistence of disturbed thalamic glucose metabolism in a case of Wernicke-Korsakoff syndrome. Psychiatry Res 2003; 124: 105–112
   PubMed Web of Science ®Google Scholar
• Gislason TB, Sjogren M, Larsson L, Skoog I. The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85 year olds. J Neurol Neurosurg Psychiatry 2003; 74: 867–871
   PubMed Web of Science ®Google Scholar
• Goforth H W, Konopka L, Primeau M, et al. Quantitative electroencephalography in frontotemporal dementia with methylphenidate response: a case study. Clin EEG Neurosci 2004; 35: 108–111
   PubMed Web of Science ®Google Scholar
• Herrmann N, Lanctot KL. Do atypical antipsychotics cause stroke?. CNS Drugs 2005; 19: 91–103
   PubMed Web of Science ®Google Scholar
• Jordan S, Koprivica V, Dunn R, Tottori K, Kikuchi T, Altar CA. In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function. Eur J Pharmacol 2004; 483: 45–53
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261–276
   PubMed Web of Science ®Google Scholar
• Knable MB, Weinberger DR. Dopamine, the prefrontal cortex and schizophrenia. J Psychopharmacol 1997; 11: 123–131
   PubMed Web of Science ®Google Scholar
• Lebert F, Stekke W, Hasenbroekx C, Pasquier F. Frontotemporal dementia: a randomised, controlled trial with trazodone. Dement Geriatr Cogn Disord 2004; 17: 355–359
   PubMed Web of Science ®Google Scholar
• Li Z, Ichikawa J, Dai J, Meltzer HY. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. Eur J Pharmacol 2004; 493: 75–83
   PubMed Web of Science ®Google Scholar
• Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995; 36: 1238–1248
   PubMed Web of Science ®Google Scholar
• Mizoguchi K, Yuzurihara M, Ishige A, Sasaki H, Tabira T. Chronic stress impairs rotarod performance in rats: Implications for depressive state. Pharmacol Biochem Behav 2002; 71: 79–84
   PubMed Web of Science ®Google Scholar
• Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546–1554
   PubMed Web of Science ®Google Scholar
• Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol 2005; 4: 771–780
   PubMed Web of Science ®Google Scholar
• Procter AW, Qurne M, Francis PT. Neurochemical features of frontotemporal dementia. Dement Geriatr Cogn Disord 1999; 10(Suppl 1)80–84
   PubMed Web of Science ®Google Scholar
• Rinne JO, Laine M, Kaasinen V, Norvasuo-Heila MK, Nagren K, Helenius H. Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia. Neurology 2002; 58: 1489–1493
   PubMed Web of Science ®Google Scholar
• Santens P, De Bleecker J, Goethals P, et al. Differential regional cerebral uptake of (18)F-fluoro-2-deoxy-D-glucose in Alzheimer's disease and frontotemporal dementia at initial diagnosis. Eur Neurol 2001; 45: 19–27
   PubMed Web of Science ®Google Scholar
• Sparks DL, Markesbery WR. Altered serotonergic and cholinergic synaptic markers in Pick's disease. Arch Neurol 1991; 48: 796–799
   PubMedGoogle Scholar
• Swartz JR, Miller BL, Lesser IM, Darby AL. Frontotemporal dementia: Treatment response to serotonin selective reuptake inhibitors. J Clin Psychiatry 1997; 58: 212–216
   PubMed Web of Science ®Google Scholar
• Volkow ND, Gatley SJ, Fowler JS, Wang GJ, Swanson J. Serotonin and the therapeutic effects of ritalin. Science 2000; 288: 11
   PubMedGoogle Scholar
• Volkow ND, Wang GJ, Fowler JS, et al. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry 2004; 161: 1173–1180
   PubMed Web of Science ®Google Scholar